All In Biotech

Drug Trial Radar · NCT07951736

Posterior Default Network Modulation in Alcohol Use Disorder

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

Jun 2031

Study completion Jun 2031

Sponsor

Lead sponsor
Indiana UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First posted
Nov 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This proposal will test whether repetitive transcranial magnetic stimulation (rTMS) modulation of the brain's posterior default mode network (pDMN) will alter alcohol craving, alcohol seeking and impulsivity in men and women who have an alcohol use disorder but are not seeking treatment.

Conditions

  • Alcohol Use Disorder

Interventions

  • Continuous theta burst stimulation (cTBS)Other

    cTBS consists of a continuous train of 3-pulse bursts of neurostimulation.

  • Intermittent theta burst stimulation (iTBS)Other

    iTBS consists of 2 second trains of 3-pulse bursts of neurostimulation, alternating with 8 seconds of rest.

  • Sham TBSOther

    Sham TBS duplicates the peripheral sensations of TBS without neurostimulation

  • IV alcohol solutionDrug

    Sterile alcohol is mixed with USP saline to a concentration of 6%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pDMN BOLD responses to alcohol taste after iTBS, cTBS or sham treatment.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
  2. Change in cue-induced craving after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
  3. Change in the number of completed trials and alcohol infusions earned on a progressive ratio task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
  4. Change in impulsivity assessed using a delay discounting task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
  5. Change in pDMN BOLD responses during a delay discounting task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • IU Health University Hospital

    Indianapolis, Indiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.